Reduced surgical invasiveness combined with accurate diagnostics – enhance your patient’s benefits

Every day nearly 700 women are diagnosed with a gynaecological malignancy in Europe.¹ Thanks to national screening programmes and regular check-ups, these cancers are often detected at an early stage.^2-4 Current clinical trends are moving toward less invasive surgical approaches in these patients which, combined with precision diagnostics, are leading to a great improvement in patient prognosis and quality of life.^5-7

Sysmex supports innovation in healthcare with cutting-edge solutions.

• By implementing the sentinel lymph node biopsy concept, patients can avoid unnecessary lymphadenectomies and related morbidities.
• You no longer need radioactive markers to detect sentinel lymph nodes as the Sentimag^®/Magtrace^® system detects them magnetically.
• Patients could benefit from fast and accurate assessment of lymph nodes already during surgery.

Literature

1. Ferlay J et al. (2018): Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 103:356-387.
2. Vu M et al. (2018): Cervical cancer worldwide. Curr Probl Cancer. pii: S0147-0272(18)30134-X.
3. Ogilvie G et al. (2017): Optimizing secondary prevention of cervical cancer: Recent advances and future challenges. Int J Gynaecol Obstet. 138 Suppl 1:15-19.
4. Braun M et al. (2016): Diagnosis and Management of Endometrial Cancer. Am Fam Physician. 93(6):468-74.
5. Shisler R et al. (2018): Life after endometrial cancer: A systematic review of patient-reported outcomes. Gynecol Oncol. 148(2):403-413.
6. Frost JA et al. (2017): Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev. 10:CD007585.
7. Zigras T et al. (2017): Early Cervical Cancer: Current Dilemmas of Staging and Surgery. Curr Oncol Rep. 19(8):51.